Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Revised International Pediatric Non-Hodgkin Lymphoma Staging System

Expert panel publishes evidence-based system

An international multidisciplinary expert panel recently published a new staging system for pediatric non-Hodgkin lymphoma. The proposed system characterizes 4 stages:

Stage

Definition

I

A single tumor, excluding mediastinum and abdomen

II

A single, extranodal tumor with regional node involvement, 2 or more nodal areas on the same side of the diaphragm, or a completely resectable primary gastrointestinal tract tumor, with or without associated mesenteric node involvement

III

2 or more extranodal tumors above and/or below the diaphragm, 2 or more nodal areas above and below the diaphragm, intra-abdominal and retroperitoneal disease, including liver, spleen, kidney, and /or ovary localizations, regardless of degree of resection, with or without involving associated mesenteric nodes that are completely resectable, any paraspinal or epidural tumor, and a single bone lesion with concomitant involvement of extranodal or nonregional nodal sites

IV

Any of the stage I to III characteristics with initial involvement of the central nervous system, bone marrow, or both

Citation: Rosolen A, Perkins SL, Pinkerton CR, et al. Revised international pediatric non-Hodgkin lymphoma staging system. [published online ahead of print May 4, 2015]. J Clin Oncol. doi:10.1200/JCO.2014.59.7203.

This Week's Must Reads

Long-term data on chemo-free approach in advanced indolent lymphoma, Lockmer S et al. J Clin Oncol. 2018 Oct 4:JCO1800262. doi: 10.1200/JCO.18.00262

CAR T induced resistance in ALL, Ruella M et al. Nat Med. 2018 Oct 1. doi: 10.1038/s41591-018-0201-9

auto-FMT could help ease GVHD after transplant, Taur Y et al. Sci Transl Med. 2018 Sep 26. doi: 10.1126/scitranslmed.aap9489

Obesity tied to higher risk of clear cell RCC, Callahan CL et al. Cancer Epidemiol. 2018 Jul 18. doi: 10.1016/j.canep.2018.07.002

Partial nephrectomy for localized RCC, Cahn D et al. AUA Annual Meeting, Abstract PD07-04

Must Reads in Lymphoma & Plasma Cell Disorders

Long-term data on chemo-free approach in advanced indolent lymphoma, Lockmer S et al. J Clin Oncol. 2018 Oct 4:JCO1800262. doi: 10.1200/JCO.18.00262

Race and pruritus create cancer risk picture, Kwatra SG et al. J Am Acad Dermatol. 2018 Sep 11. doi: 10.1016/j.jaad.2018.08.044.

Adding Bv improved survival for some Hodgkin patients, Evens AM et al. J Clin Oncol. 2018 Sep 4. doi: 10.1200/JCO.2018.79.0139.

First-line chemo-free MCL combo is durable, Ruan J et al. Blood. 2018 Sep 4. doi: 10.1182/blood-2018-07-859769.

Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10